
MiMedx Group, Inc: updates and filings
Price
$3.05
November 20, 2026Market cap $453M
What Ploutos Investor adds for MiMedx
Part of Ploutos Investor, €9.99 a month
- The full history: 16 fiscal years, from 2010
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has fallen 23% since Oct 28, 2026, when the 10-Q these figures come from was filed ($3.95 then, $3.05 on Nov 20, 2026). The figures date from before that move.10-Q
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Oct 28, 2026next Jan 29, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
October 2026
July 2026
April 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 12, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Oct 28, 2026FilingForm425
- Oct 28, 2026Results of operations, Regulation FD disclosureForm8-K
- Oct 28, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Oct 16, 2026CURRENT REPORTForm425
- Oct 16, 2026Other material eventsForm8-K
- Sep 4, 2026FilingFormEFFECT
- Aug 25, 2026REGISTRATION STATEMENTFormS-4
- Aug 11, 2026FilingForm425
- Aug 11, 2026Material agreement entered, Regulation FD disclosure (amendment)Form8-K/A
- Jul 30, 2026FORM 425Form425
- Jul 30, 2026FORM 425Form425
- Jul 29, 2026FORM 425Form425
- Jul 29, 2026FORM 425Form425
- Jul 29, 2026FilingForm425
- Jul 29, 2026Results of operations, Regulation FD disclosureForm8-K
- Jul 29, 2026FilingForm425
- Jul 29, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Jul 29, 2026Material agreement entered, Regulation FD disclosureForm8-K
- Jun 16, 2026Amended articles or bylaws, shareholder voteForm8-K
- Apr 29, 2026Additional annual meeting materialFormDEFA14A
- Apr 29, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Apr 29, 2026Annual meeting proxy statementFormDEF 14A
- Apr 29, 2026Results of operations, Regulation FD disclosureForm8-K
- Apr 29, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 12, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Oct 28, 2026 | 425 | Filing | Document |
| Oct 28, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Oct 28, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Oct 16, 2026 | 425 | CURRENT REPORT | Document |
| Oct 16, 2026 | 8-K | Other material events | Document |
| Sep 4, 2026 | EFFECT | Filing | Document |
| Aug 25, 2026 | S-4 | REGISTRATION STATEMENT | Document |
| Aug 11, 2026 | 425 | Filing | Document |
| Aug 11, 2026 | 8-K/A | Material agreement entered, Regulation FD disclosure (amendment) | Document |
| Jul 30, 2026 | 425 | FORM 425 | Document |
| Jul 30, 2026 | 425 | FORM 425 | Document |
| Jul 29, 2026 | 425 | FORM 425 | Document |
| Jul 29, 2026 | 425 | FORM 425 | Document |
| Jul 29, 2026 | 425 | Filing | Document |
| Jul 29, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Jul 29, 2026 | 425 | Filing | Document |
| Jul 29, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Jul 29, 2026 | 8-K | Material agreement entered, Regulation FD disclosure | Document |
| Jun 16, 2026 | 8-K | Amended articles or bylaws, shareholder vote | Document |
| Apr 29, 2026 | DEFA14A | Additional annual meeting material | Document |
| Apr 29, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Apr 29, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Apr 29, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Apr 29, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Mar 6, 2007.
The full analysis
What do MiMedx's filings show?
The filings are where every one of MiMedx's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.